{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:21:15Z","timestamp":1762917675056},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.eimc.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T04:47:47Z","timestamp":1454820467000},"page":"633-638","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Seroprevalencia de anticuerpos frente al virus de la varicela z\u00f3ster tras la introducci\u00f3n reciente de la vacunaci\u00f3n infantil universal en la Comunidad de Madrid"],"prefix":"10.1016","volume":"34","author":[{"given":"Luis","family":"Garc\u00eda-Comas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Ordob\u00e1s Gav\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Sanz Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Ramos Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Angeles","family":"Guti\u00e9rrez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Barranco Ord\u00f3\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2016.01.003_bib0155","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2016.01.003_bib0160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2016.01.003_bib0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2016.01.003_bib0170","unstructured":"European Centre for Disease Prevention and Control. Varicella vaccine in the European Union Stockholm: ECDC; 2015 [consultado 31 Ene 2015]. Disponible en: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Varicella-Guidance-2015.pdf"},{"key":"10.1016\/j.eimc.2016.01.003_bib0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0213-9111(04)72018-X","article-title":"Carga de enfermedad atribuible a las afecciones inmunoprevenibles en la poblaci\u00f3n infantojuvenil espa\u00f1ola","volume":"18","author":"Cort\u00e9s","year":"2004","journal-title":"Gac Sanit"},{"key":"10.1016\/j.eimc.2016.01.003_bib0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/pgmj.2005.038984","article-title":"Chickenpox, chickenpox vaccination, and shingles","volume":"82","author":"Welsby","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.eimc.2016.01.003_bib0185","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: Implication for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2016.01.003_bib0190","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1086\/522131","article-title":"Risk of herpes zoster in adults immunized with varicella vaccine","volume":"197","author":"Hambleton","year":"2008","journal-title":"JID."},{"key":"10.1016\/j.eimc.2016.01.003_bib0195","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2105\/AJPH.2009.160002","article-title":"Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination","volume":"100","author":"Donahue","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.eimc.2016.01.003_bib0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/S1135-57272001000100003","article-title":"La clasificaci\u00f3n de clase social de Goldthorpe: marco de referencia para la propuesta de medici\u00f3n de la clase social del grupo de trabajo de la Sociedad Espa\u00f1ola de Epidemiolog\u00eda","volume":"75","author":"Regidor","year":"2001","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"10.1016\/j.eimc.2016.01.003_bib0205","unstructured":"Censo de poblaci\u00f3n y vivienda. Instituto de Estad\u00edstica de la Comunidad de Madrid [consultado 16 Feb 2015]. Disponible en: http:\/\/www.madrid.org\/iestadis\/fijas\/estructu\/demograficas\/censos\/estructucensos.htm"},{"key":"10.1016\/j.eimc.2016.01.003_bib0210","unstructured":"D\u00edez-Ga\u00f1\u00e1n L, Subdirecci\u00f3n de promoci\u00f3n de la salud y prevenci\u00f3n de la Comunidad de Madrid. H\u00e1bitos de Salud en la poblaci\u00f3n adulta de la Comunidad de Madrid, 2011 [consultado 6 Feb 2015]. Bolet\u00edn Epidemiol\u00f3gico de la Comunidad de Madrid; 2012, 18. http:\/\/www.madrid.org\/cs\/Satellite?cid=1265618561630&language=es&pagename=PortalSalud%2FPage%2FPTSA_servicioPrincipal&vest=1265618561630#"},{"key":"10.1016\/j.eimc.2016.01.003_bib0215","unstructured":"Direcci\u00f3n General de Prevenci\u00f3n y Promoci\u00f3n de la Salud de la Comunidad de Madrid. II Encuesta de Serovigilancia de la Comunidad de Madrid. A\u00f1os 1993-1994. Documento T\u00e9cnico de salud p\u00fablica n.\u00b0 29."},{"key":"10.1016\/j.eimc.2016.01.003_bib0220","doi-asserted-by":"crossref","unstructured":"Direcci\u00f3n General de Salud P\u00fablica de la Comunidad de Madrid. III Encuesta de Serovigilancia de la Comunidad de Madrid. Bolet\u00edn Epidemiol\u00f3gico de la Comunidad de Madrid, 2002; vol. 8 [consultado 16 Feb 2015]. Disponible en: http:\/\/www.madrid.org\/cs\/Satellite?cid=1265618561630&language=es&pagename=PortalSalud%2FPage%2FPTSA_servicioPrincipal&vest=1265618561630#","DOI":"10.36300\/remasp.2019.023"},{"key":"10.1016\/j.eimc.2016.01.003_bib0225","unstructured":"Centro Nacional de Epidemiolog\u00eda. ISCIII. Estudio Seroepidemiol\u00f3gico: situaci\u00f3n de las enfermedades vacunables en Espa\u00f1a. 2000 [consultado 16 Feb 2015]. Disponible en: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-enfermedades\/SEROEPIDEMIOLOGICO.pdf"},{"key":"10.1016\/j.eimc.2016.01.003_bib0230","unstructured":"Direcci\u00f3n General de Salud P\u00fablica. Gobierno del Principado de Asturias. II Encuesta de Seroprevalencia de Asturias 2009-2011."},{"key":"10.1016\/j.eimc.2016.01.003_bib0235","unstructured":"Departamento de Sanidad y Consumo del Gobierno Vasco. I Encuesta de Seroprevalencia de la Comunidad Aut\u00f3noma del Pa\u00eds Vasco. 2011 [consultado 16 Feb 2015]. Disponible en: http:\/\/www.euskadi.net\/r332732\/es\/contenidos\/informacion\/vacunas_epidem\/es_4330\/adjuntos\/seroprevalencia.pdf"},{"key":"10.1016\/j.eimc.2016.01.003_bib0240","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","article-title":"The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region","volume":"25","author":"Nardone","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2016.01.003_bib0245","first-page":"604","article-title":"Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989","volume":"87","author":"White","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2016.01.003_bib0250","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Vaccination with measles, mumps and rubella vaccine and varicella vaccine: Safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2016.01.003_bib0255","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"V\u00e1zquez","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2016.01.003_bib0260","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/INF.0b013e31829ae263","article-title":"The effectiveness of varicella vaccination in children in germany: A case-control study","volume":"32","author":"Liese","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2016.01.003_bib0265","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/INF.0b013e3181d7380e","article-title":"The effectiveness of varicella vaccine in China","volume":"29","author":"Fu","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimc.2016.01.003_bib0270","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2016.01.003_bib0275","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination: Implications for interval between 2 doses","volume":"32","author":"Bonani","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"Supl","key":"10.1016\/j.eimc.2016.01.003_bib0280","first-page":"58","article-title":"Situaci\u00f3n de la varicela en la Comunidad de Madrid en 2007. Efectividad de la vacuna","volume":"22","author":"Polentinos","year":"2008","journal-title":"Gac Sanit."},{"key":"10.1016\/j.eimc.2016.01.003_bib0285","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.32.20552","article-title":"Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012","volume":"18","author":"Garc\u00eda Cenoz","year":"2013","journal-title":"Euro Surveill"},{"issue":"Supl E3","key":"10.1016\/j.eimc.2016.01.003_bib0290","first-page":"132","article-title":"Evoluci\u00f3n de la incidencia de la varicela en la Comunidad de Madrid en los 5 a\u00f1os posteriores a la introducci\u00f3n de la vacuna (2007-2011)","volume":"26","author":"Cabrera Miranda","year":"2012","journal-title":"Gac Sanit."},{"issue":"Supl E3","key":"10.1016\/j.eimc.2016.01.003_bib0295","first-page":"133","article-title":"Evoluci\u00f3n de la incidencia de herpes z\u00f3ster en la Comunidad de Madrid en los 5 a\u00f1os posteriores a la introducci\u00f3n de la vacuna frente a varicela (2007-2011)","volume":"26","author":"Cabrera Miranda","year":"2012","journal-title":"Gac Sanit."},{"key":"10.1016\/j.eimc.2016.01.003_bib0300","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2013.09.035","article-title":"Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005-2012","volume":"68","author":"Esteban-Vasallo","year":"2014","journal-title":"J Infect"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X16000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X16000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T15:19:59Z","timestamp":1654269599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X16000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0213005X16000288"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2016.01.003","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalencia de anticuerpos frente al virus de la varicela z\u00f3ster tras la introducci\u00f3n reciente de la vacunaci\u00f3n infantil universal en la Comunidad de Madrid","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}